Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

Four SPACs Tap Markets for $530 Million Total (Law360)

Related Content

Health Headlines: January 2026

Historic False Claims Act Enforcement Illustrates Trump Administration’s Focus on Healthcare Fraud

Enforcement Intensifies as Medicaid Cuts Take Hold

2026 HSR Thresholds Announced: $133.9 million

Health Headlines: December 2025

Mass Arbitration: The Risk Lurking in Consumer Agreements

How Medicaid Cuts Could Reshape the Business of Health

Health Headlines: November 2025

Goodwin Continues to Lead 2025 League Tables

Biotech Fundraising A Good Sign For Public Markets (Law360)

Flow Neuroscience Announces FDA Approval of World’s First At-Home Brain Stimulation Treatment for Depression

Inside Goodwin's Client Immersion Program for Junior Associates with Lynda Galligan and Josh Klatzkin (Big Law Life)

Trump’s Drug Pricing Proposals Draw Legal Questions From Pharma (Bloomberg Law)

What JPM Tells Us About Healthcare Deals In 2026 (Law360 Healthcare Authority)

Biopharma Industry Cheers US, EU's Joint AI Principles (Law360 Healthcare Authority)

Stago Enters Into Exclusive Negotiations With ARCHIMED and La Caisse

Healthcare

Life Sciences

Private Equity

Technology

Special Purpose Acquisition Companies (SPACs)